CLINIMIX
BAXTER CORPORATION
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is CLINIMIX discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that CLINIMIX 520MG 1.04G 1.04G 290MG 290MG 310MG 310MG 5G 240MG 20MG 210MG 90MG 210MG 220MG 230MG has been permanently discontinued (last updated August 19, 2025). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is CLINIMIX not available?
The reason the manufacturer reported: Business reasons.
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02013886
Strength
520MG 1.04G 1.04G 290MG 290MG 310MG 310MG 5G 240MG 20MG 210MG 90MG 210MG 220MG 230MG
Dosage Form
SOLUTION
Route
INTRAVENOUS
Active Ingredient
L-ARGININE GLYCINE L-ALANINE METHIONINE L-LYSINE HYDROCHLORIDE L-PHENYLALANINE HYDROCHLORIDE L-LEUCINE HYDROCHLORIDE DEXTROSE L-ISOLEUCINE L-TYROSINE L-PROLINE TRYPTOPHAN L-THREONINE HISTIDINE L-VALINE
Tier
Unrated
Last Updated
2025-08-19
Reason for Shortage
Business reasons
Other Products from BAXTER CORPORATION
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 00438014
DIN 00786292
DIN 00438049
DIN 00786209
DIN 00437999
DIN 00786217
DIN 00438030
DIN 00438022
DIN 00438006
DIN 00828602
900MG · DIN 00060208
900MG · DIN 00786160